Voluntary announcement InSilico Medicine triggers a milestone payment in AI-driven R&D collaboration with servier for achieving early drug discovery milestone
Filed with HKEX · Stock code 3696 ·
6ix is reading this filing.
View original source (HKEXnews)InSilico Medicine Cayman TopCo on 6ix
Earlier from InSilico Medicine Cayman TopCo
- Voluntary announcement InSilico Medicine nominates peripheral-restricted VAV1 molecular glue degrader for potential treatment of autoimmune diseases
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
- Voluntary announcement InSilico Medicine nominates next-generation small molecule GIPR antagonist for potential intervention of obesity and related disorders
- Voluntary announcement InSilico Medicine entered into an AI co-development collaboration with a contract value up to tens of millions of U.S. dollars to build and commercialize foundation models for biology
- Insilico Medicine Opens AI Longevity Discovery Toolkit to Researchers Worldwide in Cell Cover Study
Follow InSilico Medicine Cayman TopCo into a list and get an email when it puts out news.
Follow InSilico Medicine Cayman TopCo